| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442692 | European Journal of Cancer | 2015 | 8 Pages |
Abstract
The UKW3 trial provides some reassurance that biopsy should not automatically lead to 'upstaging' of WT. Further assessment of this controversial area is required. Comparison of local relapse rates in a multinational trial in which the United Kingdom (UK) continued the practice of routinely biopsying all patients in contrast to the standard European approach will afford this opportunity and is planned.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Irtan, M. Jitlal, J. Bate, M. Powis, G. Vujanic, A. Kelsey, J. Walker, C. Mitchell, D. Machin, K. Pritchard-Jones,